Fluticasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H27F3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CUT2W21N7U, chemically known as s-(fluoromethyl) 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate, 17-propionate but generally known as fluticasone, which bears US NIH Compound Identifier 54580. European Medicines Agency schedules Fluticasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07760MIG. The term FLUTICASONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules fluticasone in its Anatomical Therapeutic Chemical (ATC) Classification. FLUTICASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluticasone under HS 29309085 and SITC 51549. As of Q4 2014, FLUTICASONE remains the US FDA Preferred Term for this commodity. Fluticasone bears US NLM identifiers UMLS ID C0082607 and NCI Concept Code C61767. SMILES: S(C(=O)C1(OC(=O)CC)C2(C(C3C(F)(C(O)C2)C2(C(=CC(=O)C=C2)C(F)C3)C)CC1C)C)CF.